Cure of hemophilia A by orthotopic liver transplantation
View abstract on PubMed
Summary
This summary is machine-generated.Liver transplantation cured a hemophilia A patient's need for factor replacement therapy. However, human immunodeficiency virus (HIV) complications led to death, highlighting challenges in treating multitransfused hemophiliacs.
Area Of Science
- Hepatology
- Hematology
- Transplantation immunology
Background
- Hemophilia A patients often develop chronic liver disease due to frequent blood transfusions.
- Orthotopic liver transplantation is a potential treatment for end-stage liver disease in hemophiliacs.
Observation
- A patient with hemophilia A and transfusion-associated end-stage chronic liver disease underwent liver transplantation.
- The patient survived for 27 months post-transplantation without requiring factor VIII replacement therapy.
Findings
- Successful liver transplantation effectively cured the patient's hemophilia A, eliminating the need for factor VIII.
- The patient had pre-existing human immunodeficiency virus (HIV) antibodies and died from acquired immunodeficiency syndrome (AIDS) complications.
Implications
- Liver transplantation can resolve hemophilia A in patients with liver cirrhosis.
- High prevalence of HIV infection in multitransfused hemophiliacs may limit the applicability of liver transplantation as a cure.